121 related articles for article (PubMed ID: 1578906)
1. Allogeneic and autologous bone marrow transplantation in AML.
Santos GW
Leukemia; 1992; 6 Suppl 2():102-3. PubMed ID: 1578906
[No Abstract] [Full Text] [Related]
2. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients.
Carella AM; Piatti G; Frassoni F; Maraone MP; Van Lint MT; Bacigalupo A
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469
[No Abstract] [Full Text] [Related]
4. Allogeneic bone marrow transplantation in children with ANL: Italian experience. AIEOP Group and the GITMO.
Dini G; Abla O; Uderzo C; Polchi P; Locatelli F; Di Bartolomeo P; Arcese W; Messina C; Bandini G; Andolina M
Bone Marrow Transplant; 1991; 7 Suppl 3():76-7. PubMed ID: 1855094
[No Abstract] [Full Text] [Related]
5. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry.
Ringdén O; Horowitz MM
Transplant Proc; 1989 Feb; 21(1 Pt 3):2989-92. PubMed ID: 2650409
[No Abstract] [Full Text] [Related]
7. Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
Zittoun R; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P; Gattringer C; Petti MC; Solbu G
Leukemia; 1992; 6 Suppl 2():114-5. PubMed ID: 1578909
[No Abstract] [Full Text] [Related]
8. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
9. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
[TBL] [Abstract][Full Text] [Related]
10. Allogenic versus autologous marrow transplantation for patients with acute non lymphoblastic leukemia in first complete remission.
Carella AM; Bacigalupo A
Haematologica; 1990; 75(2):198. PubMed ID: 2358214
[No Abstract] [Full Text] [Related]
11. BAVC regimen in CR AML patients.
Meloni G; Vignetti M; De Fabritiis P; Petti MC; Pinto MR; Testi AM; Vegna ML; Mandelli F
Bone Marrow Transplant; 1991; 7 Suppl 2():134. PubMed ID: 1878679
[No Abstract] [Full Text] [Related]
12. Prevention of graft versus host disease following allogeneic bone marrow transplantation.
Powles RL; Goss GD; Millar J; Maitland J; Borthwick-Clark C; Al-Jundi A
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):133-8. PubMed ID: 3914738
[No Abstract] [Full Text] [Related]
13. Allogeneic bone marrow transplantation for acute leukaemia--IGCI experience. International Group for Chemo-Immunotherapy.
Labar B; Masszi T; Morabito F; Mistrik M; Holowiecki J; Bogdanić V; Nemet D; Mrsić M; Krieger O; Lutz D
Bone Marrow Transplant; 1996 Jun; 17(6):1009-12. PubMed ID: 8807107
[TBL] [Abstract][Full Text] [Related]
14. [Results of hematopoietic cell transplantation in the first complete remission in children with acute myeloid leukemia from an intermediate risk group].
SDyshlevaia ZM; Skorobogatova EV; Maschan MA; Shipitsyna IP; Skvortsova IuV; Trakhtman PE; Balashov DN; Pashko IuV; Kurnikova EE; Suntsova EV; Goronkova OV; Solopova GG; Baĭdil'dina DD; Kalinina II; Khachatrian LA; Shneĭder MM; Maschan AA
Ter Arkh; 2010; 82(7):34-40. PubMed ID: 20853607
[TBL] [Abstract][Full Text] [Related]
15. [Results of allogenic and autologous bone marrow transplantation in children with acute myeloid leukemia].
Hermann J; Fuchs D; Prager J; Palme H; Müller A; Füller J; Vogelsang H; Zintl F
Kinderarztl Prax; 1992 Apr; 60(2):35-9. PubMed ID: 1608183
[TBL] [Abstract][Full Text] [Related]
16. [Allogeneic bone marrow transplantation and myeloid leukemia in the chronic and accelerated stages].
Gyger M; Perreault C; Bélanger R; Bonny Y; David M; Boileau J; Lavallée R; Lacombe M; D'Angelo G; Tawil E
Union Med Can; 1988; 117(2):169, 173-4, 177-8. PubMed ID: 3041661
[No Abstract] [Full Text] [Related]
17. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
[TBL] [Abstract][Full Text] [Related]
18. Autologous and allogeneic bone marrow transplantation for childhood acute nonlymphoblastic leukemia.
Vowels M; Stevens M; Tiedemann K; Brown R
Transplant Proc; 1992 Feb; 24(1):184-5. PubMed ID: 1539237
[No Abstract] [Full Text] [Related]
19. Allogeneic versus autologous marrow transplantation for patients with acute myeloid leukemia in first marrow remission. An update of the Genoa experience with 159 patients.
Carella AM; Frassoni F; Damasio E; Santini G; Bacigalupo A; Marmont AM; Vitale V
Leukemia; 1992 Nov; 6 Suppl 4():78-81. PubMed ID: 1434841
[No Abstract] [Full Text] [Related]
20. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.
Novitzky N; Thomas V; du Toit C; McDonald A
Biol Blood Marrow Transplant; 2011 Jun; 17(6):875-84. PubMed ID: 20870030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
